Liu Christine K, Cheung Katharine L, Tamura Manjula Kurella
Section of Geriatric Medicine, Division of Primary Care and Population Health, School of Medicine, Stanford University, Stanford, California; Geriatric Research and Education Clinical Center, Veteran Affairs Palo Alto Health Care System, Palo Alto, California.
Division of Nephrology, Larner College of Medicine, University of Vermont, Burlington, Vermont; Center on Aging, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Am J Kidney Dis. 2025 Jul;86(1):97-108. doi: 10.1053/j.ajkd.2025.01.007. Epub 2025 Mar 3.
Dementia describes when a person has cognitive limitations that impede function. Persons with kidney disease are unduly impacted by dementia: up to 87% of the dialysis population has cognitive impairment. In this review, we discuss the diagnosis and management of dementia, including the role of cerebrovascular disease and other risk factors. We review the available screening tools for the diagnosis of dementia. We discuss how the diagnosis of dementia differs from the diagnosis of mild cognitive impairment and also detail how delirium and depression can mimic dementia. In terms of treatments for dementia, we highlight 4 components. First, we describe pharmacologic treatments for the management of dementia, including the cholinesterase inhibitors N-methyl-d-aspartate antagonists as well as the newer antiamyloid antibody drugs for Alzheimer dementia. Second, we discuss the importance of nonpharmacologic interventions for the management of dementia, especially exercise. Third, we review approaches for the behavioral and neuropsychiatric symptoms associated with dementia, including potential medication management. Fourth, we highlight the essential and valuable role of caregivers in both the diagnosis and management of dementia. We conclude with key considerations about the impact of dementia for persons receiving dialysis and the role of dementia in kidney transplant evaluation.
痴呆症是指一个人存在妨碍其功能的认知局限。肾病患者受到痴呆症的过度影响:高达87%的透析人群存在认知障碍。在本综述中,我们讨论了痴呆症的诊断和管理,包括脑血管疾病和其他风险因素的作用。我们回顾了现有的痴呆症诊断筛查工具。我们讨论了痴呆症的诊断与轻度认知障碍的诊断有何不同,还详细阐述了谵妄和抑郁症如何可能类似痴呆症。在痴呆症的治疗方面,我们强调4个方面。首先,我们描述了用于管理痴呆症的药物治疗,包括胆碱酯酶抑制剂、N-甲基-D-天冬氨酸拮抗剂以及用于阿尔茨海默病痴呆症的新型抗淀粉样蛋白抗体药物。其次,我们讨论了非药物干预对痴呆症管理的重要性,尤其是运动。第三,我们回顾了与痴呆症相关的行为和神经精神症状的处理方法,包括潜在的药物管理。第四,我们强调了护理人员在痴呆症诊断和管理中的重要且有价值的作用。我们最后总结了关于痴呆症对透析患者的影响以及痴呆症在肾移植评估中的作用的关键考虑因素。